Canada markets open in 8 hours 24 minutes

Advanced Oncotherapy plc (AVO.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
1.92500.0000 (0.00%)
At close: 04:23PM BST
Currency in GBp

Valuation Measures4

Market Cap (intraday) 10.44M
Enterprise Value 67.68M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.17
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.77

Trading Information

Stock Price History

Beta (5Y Monthly) 0.07
52-Week Change 3-67.92%
S&P500 52-Week Change 323.57%
52 Week High 30.0870
52 Week Low 30.0000
50-Day Moving Average 30.0192
200-Day Moving Average 30.0192

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5542.57M
Implied Shares Outstanding 6542.57M
Float 8212.84M
% Held by Insiders 147.53%
% Held by Institutions 117.83%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Jul 01, 2016

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.73%
Return on Equity (ttm)-67.34%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.05M
Net Income Avi to Common (ttm)-32.6M
Diluted EPS (ttm)-0.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.51M
Total Cash Per Share (mrq)0
Total Debt (mrq)59.74M
Total Debt/Equity (mrq)98.71%
Current Ratio (mrq)1.26
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-26.65M
Levered Free Cash Flow (ttm)-34.96M